Last reviewed · How we verify
Placebo evening
Placebo evening is an inert substance with no active pharmacological mechanism, used as a control or comparator in clinical studies.
At a glance
| Generic name | Placebo evening |
|---|---|
| Sponsor | Basque Health Service |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
As a placebo, it contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect—the patient's expectation and belief in treatment. It is typically used in randomized controlled trials to establish the true efficacy of an investigational drug by comparison to a non-active control.
Approved indications
Common side effects
Key clinical trials
- Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype (NA)
- Choline Supplementation and Cardiovascular Health (NA)
- Short Term Choline and Cardiovascular Health (NA)
- Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial (PHASE3)
- Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects (PHASE1)
- Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis (PHASE2)
- A Study of HS-10518 in Healthy Adult Premenopausal Females in China (PHASE1)
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |